TGFB1 and tuberculosis: Thus, silencing the TGF-β1 gene by the RNA interference (RNAi) technology [31], reducing the secretion of the TGF-β1 protein in macrophages, and combining first-line anti-TB drugs to facilitate Mtb clearance are tools that could increase the efficacy of anti-TB medications.